Related Experiment Video
Updated: May 16, 2026
Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
Published on: March 17, 2019
Paradoxical effects of low dose MDMA on latent inhibition in the rat
A J D Nelson1, K E Thur, C A Marsden
1School of Psychology, University of Nottingham, University Park, Nottingham, NG7 2RD, United Kingdom.
Abstract:
The cognitive effects of MDMA ('Ecstasy') are controversial, particularly in the case of acute administration of low doses. Latent inhibition (LI) refers to the reduction in conditioning to a stimulus that has received non-reinforced pre-exposure, an effect typically abolished by amphetamines and enhanced by antipsychotics. LI enhancement has also been shown using the 5-HT reuptake blocker sertraline. In the present study, the effects of MDMA (6 mg/kg, known to increase 5-HT release) were tested using 10 and 40 pre-exposures to produce weak and strong LI in controls, respectively. MDMA (injected twice, prior to pre-exposure and conditioning) significantly enhanced LI in that the effect was clearly demonstrated after only 10 pre-exposures, when it was absent in the saline controls. On its own such a profile of action would be consistent with a procognitive effect of MDMA mediated by increased availability of 5-HT. However, paradoxically the same MDMA treatment reduced LI in the 40 pre-exposures condition. This component of action is likely attributable to MDMA's actions on catecholaminergic systems and is consistent with other evidence of its adverse effects. Moreover, there were small but significant reductions in 5-HT in medial prefrontal cortex (mPFC) and amygdala assayed 7 days post MDMA administration (2 × 6 mg/kg, 24 h apart).
Insights
MDMA (Ecstasy) shows complex cognitive effects, enhancing latent inhibition (LI) at low doses by increasing serotonin, but paradoxically reducing it at higher exposures, suggesting mixed impacts.
Area of Science:
- Neuroscience
- Psychopharmacology
- Cognitive Science
Background:
- The cognitive effects of MDMA (Ecstasy) are debated, especially concerning acute low-dose administration.
- Latent inhibition (LI) is a learning process sensitive to neurotransmitter modulation, typically disrupted by amphetamines and enhanced by certain drugs.
- Previous research suggests 5-HT reuptake blockers like sertraline can enhance LI.
Purpose of the Study:
- To investigate the effects of MDMA on latent inhibition (LI) in a controlled experimental setting.
- To explore the dose-dependent and exposure-dependent cognitive impacts of MDMA, particularly its influence on learning processes.
- To examine the role of serotonin (5-HT) and catecholaminergic systems in MDMA's effects on LI.
Main Methods:
- Rats were administered MDMA (6 mg/kg) or saline, with varying pre-exposure (10 or 40 non-reinforced trials) and conditioning phases.
- Latent inhibition (LI) was measured as the reduction in conditioning due to non-reinforced pre-exposure.
- Neurotransmitter levels (5-HT) in specific brain regions (mPFC, amygdala) were assessed one week post-MDMA administration.
Main Results:
- MDMA significantly enhanced LI with 10 pre-exposures, indicating a potential procognitive effect mediated by increased 5-HT.
- Conversely, MDMA reduced LI with 40 pre-exposures, suggesting adverse effects possibly linked to catecholaminergic activity.
- A significant reduction in 5-HT levels was observed in the medial prefrontal cortex and amygdala seven days after MDMA administration.
Conclusions:
- MDMA exhibits dual effects on cognitive processes like LI, dependent on the extent of pre-exposure.
- The findings suggest MDMA's cognitive impact involves complex interactions between serotonin and catecholaminergic systems.
- Potential adverse effects of MDMA on cognitive function and neurochemistry warrant further investigation.
